| Patients with COVID-19, OR (95% CI) | p-value | Patients without COVID-19, OR (95% CI) | p-value |
---|---|---|---|---|
Frailty assessed using CFS as a continuous variable | ||||
CFS | 1.29 (1.19–1.41) | < 0.001 | 1.24 (1.11–1.37) | < 0.001 |
Male sex | 1.59 (1.25–2.04) | < 0.001 | 1.29 (0.94–1.77) | 0.12 |
ANZROD | 1.07 (1.06–1.08) | < 0.001 | 1.05 (1.04–1.06) | < 0.001 |